Pär Thuresson
Direktor/Vorstandsmitglied bei EUROCINE VACCINES AB
Ursprung des Netzwerks ersten Grades von Pär Thuresson
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Pär Thuresson
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CEGEDIM | Packaged Software | Sales & Marketing | |
ACTIVE BIOTECH AB | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member | |
Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
SBL Vaccin AB
SBL Vaccin AB Pharmaceuticals: MajorHealth Technology SBL Vaccin AB manufactures and distributes vaccines. Its products are used for the treatment of polio, diarrhoea, and cholera diseases. The company distributes products to the healthcare centers, hospitals, schools, and industrial healthcare units. SBL Vaccin was founded in 1957 and is located in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chief Operating Officer | |
Stockholm School of Economics | College/University | Masters Business Admin | |
University of Uppsala | College/University | Graduate Degree Doctorate Degree | |
Accuro Immunology AB
Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
THERADIAG | Medical Specialties | Chairman | |
Astra Pharmaceuticals AB | Corporate Officer/Principal Corporate Officer/Principal | ||
ESSEC Business School | College/University | Masters Business Admin | |
University of Lisbon | College/University | Doctorate Degree | |
University of Lyon | College/University | Doctorate Degree | |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chief Executive Officer | |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
XSPRAY PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
ISIRV Ltd.
ISIRV Ltd. Miscellaneous Commercial ServicesCommercial Services ISIRV Ltd. promotes the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Siena | College/University | Corporate Officer/Principal | |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SPAGO NANOMEDICAL AB | Biotechnology | Chairman | |
Healthy Bizniz Europe AB | Director/Board Member | ||
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of XNK Therapeutics AB, CellProtect Nordic Pharmaceuticals AB is a clinical-stage biotechnology company based in Huddinge, SE. CellProtect Nordic Pharmaceuticals is one of the pioneering companies in the field of cell therapy, developing unique and individualized natural killer (NK) cell-based cancer therapies. The Swedish company has built a tailor-made GMP clean room facility for manufacturing clinical products and is currently evaluating its lead product, evencaleucel, in a randomized, controlled, phase II study for the treatment of multiple myeloma. The company was founded in 2012 and the CEO is Johan Liwing. | Pharmaceuticals: Major | Director/Board Member | |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Consultant / Advisor | |
NANEXA AB | Medical Specialties | Chairman Chairman | |
AAAS Fellowship Programs, Inc.
AAAS Fellowship Programs, Inc. Insurance Brokers/ServicesFinance AAAS Fellowship Programs, Inc. provides health insurance services. The company is headquartered in Washington, DC. | Insurance Brokers/Services | Corporate Officer/Principal | |
NEXTCELL PHARMA AB | Pharmaceuticals: Major | Chairman | |
AJ Biologics Sdn. Bhd.
AJ Biologics Sdn. Bhd. BiotechnologyHealth Technology AJ Biologics Sdn. Bhd develops and manufactures biological products. It specializes in vaccine formulations. The company is headquartered in Kuala Lumpur, Malaysia. | Biotechnology | Chief Executive Officer | |
Helsinn Healthcare SA /Venture/
Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Investment Managers | Private Equity Investor | |
Schering-Plough SAS
Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Founded in 1900, Schering-Plough SAS is a French pharmaceutical company that manufactures pharmaceutical products. Part of Merck & Co., Inc., the company is based in Puteaux, France. | Pharmaceuticals: Major | Director/Board Member | |
VisMederi Srl
VisMederi Srl BiotechnologyHealth Technology VisMederi Srl specializes in vaccine assessment and analytical testing of biological samples. The private company is based in Siena, Italy and was founded by Simona Piccirella. The Italian company also provides validation of bioanalytical methods, with a focus on quality, experience, and reliability. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Eurocince Securities AB
Eurocince Securities AB Real Estate DevelopmentFinance Eurocince Securities AB is a Swedish company that manages fixed and movable property. The private company is based in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
National Centre For Research & Development /Poland/
National Centre For Research & Development /Poland/ Miscellaneous Commercial ServicesCommercial Services The National Centre for Research and Development in Poland provides executive agency services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Drug Abuse Sciences | Chief Executive Officer | ||
Health Technology Holding Srl
Health Technology Holding Srl Investment ManagersFinance Health Technology Holding Srl (HTC), is a venture capital subsidiary of Gefim SpA founded in 2019. The firm is headquartered in Milan, Italy. | Investment Managers | Chairman | |
XNK Therapeutics AB
XNK Therapeutics AB Pharmaceuticals: MajorHealth Technology XNK Therapeutics AB operates as a technology platform which leads research on NK cells at Karolinska Institutet in Stockholm. The company was founded in 2012 and is headquartered in Huddinge, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Limula Biotech
Limula Biotech Miscellaneous Commercial ServicesCommercial Services Limula Biotech operates as an automated gene therapy manufacturing platform. | Miscellaneous Commercial Services | Director/Board Member | |
Simplexia AB
Simplexia AB BiotechnologyHealth Technology Simplexia AB is a company based in Gothenburg, Sweden that aims to launch the first vaccine for the treatment and prevention of genital herpes. The Swedish company is driven by the goal to curtail and treat infection with herpes simplex virus (HSV), one of the world's most prevalent sexually transmitted diseases. The team at Simplexia is composed of experts in pharmaceutical development, including Prof. Jan-Åke Liljeqvist and the Department of Virology at the Sahlgrenska Academy. The vaccine is based on research that showed glycoproteins from HSV-1 and 2, when administered as a vaccine, are highly immunogenic and provide protection in mouse models. | Biotechnology | Chairman | |
Dilafor Incentive AB | Director/Board Member | ||
BIOSERGEN AB | Biotechnology | Director/Board Member | |
MRGN Advisors SARL | Chief Executive Officer | ||
Laboratorios Biofarma SA | Sales & Marketing | ||
ALZINOVA AB | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Schweden | 28 |
Frankreich | 7 |
Vereinigte Staaten | 5 |
Italien | 4 |
Vereinigtes Königreich | 3 |
Sektoral
Health Technology | 22 |
Commercial Services | 8 |
Consumer Services | 8 |
Finance | 6 |
Distribution Services | 3 |
Operativ
Director/Board Member | 63 |
Chairman | 38 |
Corporate Officer/Principal | 28 |
Chief Executive Officer | 18 |
Independent Dir/Board Member | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Pär Thuresson
- Unternehmensverbindungen